phenylalanine has been researched along with pentoxifylline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breuille, D; Buffiere, C; Dardevet, D; Denis, P; Grizard, J; Obled, C; Vary, T; Voisin, L | 1 |
| Estrada, EY; Mobashery, S; Rosenberg, GA | 1 |
| Chen, X; Ding, HF; Lang, L; Liu, G; Sun, SY; Yan, C | 1 |
3 other study(ies) available for phenylalanine and pentoxifylline
| Article | Year |
|---|---|
Pentoxifylline improves insulin action limiting skeletal muscle catabolism after infection.
Topics: Analysis of Variance; Animals; Culture Techniques; Escherichia coli Infections; Forelimb; Insulin; Male; Muscle Proteins; Muscle, Skeletal; Pentoxifylline; Phenylalanine; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tyrosine | 1999 |
Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents.
Topics: Animals; Benzyl Compounds; Blood-Brain Barrier; Dexamethasone; Dimethyl Sulfoxide; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Encephalitis; Endothelial Cells; Enzyme Inhibitors; Genetic Variation; Heterocyclic Compounds, 1-Ring; Inflammation Mediators; Lipopolysaccharides; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Pentoxifylline; Phenylalanine; Rats; Rats, Inbred WKY; Solvents; Species Specificity; Succinates; Sulfones; Thiophenes | 2007 |
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
Topics: CRISPR-Cas Systems; Gene Targeting; Genes; Genes, Reporter; Genetic Engineering; Humans; Internal Ribosome Entry Sites; Transcription, Genetic | 2015 |